智通财经APP获悉，2月5日，辉瑞(PFE.US)宣布，Jeffrey Legos博士将加入公司并担任首席肿瘤官，负责领导公司的肿瘤学研发工作，监督从临床前到后期临床开发活动的所有职能。Legos博士将向辉瑞首席科学官兼研发总裁、医学博士Chris Boshoff汇报工作，并将在辉瑞研发领导团队中代表肿瘤学部门。Legos博士将接替临时首席肿瘤官Roger Dansey，后者将如前所述过渡到退休状态。
Legos博士拥有20多年成功领导大型跨国团队的经验，涵盖肿瘤学药物开发的所有职能和阶段，已获得40多项全球药品和辅助诊断的监管批准，包括新分子实体、产品管线拓展和器械的上市前批准。加入辉瑞之前，Legos博士在诺华担任执行副总裁兼肿瘤学和血液学开发全球主管。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.